The present invention relates to a method for producing a
stock solution of activated and amplified lymphocytes, comprising the steps of: (1) culturing and activating lymphocytes by co-culturing
peripheral blood mononuclear cells (PBMCs) obtained by centrifuging autologous
peripheral whole blood with a
lymphocyte activator in a serum-
free medium; and (2) culturing and activating lymphocytes so that the initial density of the
peripheral blood mononuclear cells in the serum-
free medium is (0.2 to 1.6) × 10 6 (1) a serum-
free medium having a concentration of (0.5 to 5) × 10 cells / ml, the serum-free medium being any one selected from KBM 581, GT-T551 H3, and a combination thereof; and (2) culturing the cultured activated lymphocytes produced in the step (1) in a concentration of (0.5 to 5) × 10 cells / ml. 6 The method includes the steps of: (1) producing a
lymphocyte activation culture by subculturing the lymphocytes in a serum-free medium at a
cell density of 100000000 / ml, the subculturing temperature being 37.0°C±1.0°C and the activation
culture environment containing 7.5%±1.0% CO2; (2) adding 5-10 times the volume of serum-free medium to the
lymphocyte activation culture obtained by the subculturing in step (2) to perform amplification culture, the number of generations of the amplification culture being 1-5; and (3) centrifuging, washing, and collecting the activated and amplified lymphocytes to obtain a
stock solution of activated and amplified lymphocytes. The activated and amplified lymphocytes produced by the present invention have advantages such as
high cell expansion efficiency,
high cell survival rate, stable
cell activity, long
effective time, safety and effectiveness, and small side effects, and effectively solve the important problems in tumor treatment technology using individualized immune cells.